[144] Life360, Inc. SEC Filing

Rhea-AI Filing Summary

Life360, Inc. (Form 144) – Proposed Insider Sale

Life360 has filed a Form 144 indicating that an insider intends to sell 7,930 common shares, representing less than 0.01% of the 76.5 million shares outstanding. The proposed sale, to be executed through Fidelity Brokerage Services, carries an estimated aggregate market value of $510,771 and is targeted for 14 July 2025 on the NASDAQ.

• Security origin: Shares stem from options granted on 12 Apr 2022 and exercised for cash on 14 Jul 2025.
• Prior activity: During the past three months the same insider sold 7,942 shares for $489,465 (13 Jun 2025).
• Rule 10b5-1/144 compliance: The filer certifies no undisclosed material adverse information and affirms compliance with Rule 10b5-1 if a trading plan applies.

The filing signals continued, but modest, insider profit-taking. Given the very small percentage of shares involved, market impact should be limited; however, investors often view repeated insider sales as a mild negative sentiment indicator.

Positive

• Transparent disclosure under Rule 144 demonstrates compliance and reduces governance risk.
• Insignificant dilution: 7,930 shares represent less than 0.01% of total shares outstanding.

Negative

• Continued insider selling: Second sale within three months totaling roughly $1 million in proceeds could pressure investor sentiment.

Insights

Securities Analyst

TL;DR: Minor insider sale (<0.01% float) – limited financial impact, slight sentiment negative.

The proposed sale of 7,930 shares worth about $0.51 million is immaterial to Life360’s capital structure, yet it follows a similar $0.49 million disposal in June. Recurrent sales may hint at insider diversification rather than concern, but could pressure short-term sentiment. No operational metrics are disclosed, and the transaction complies with Rule 144. Overall impact is neutral from a valuation standpoint; volumes are too small to affect supply-demand dynamics meaningfully.

Corporate Governance Expert

TL;DR: Routine Rule 144 notice; signals transparency, but repeated sales warrant monitoring.

Filing shows adherence to disclosure requirements, mitigating governance risk. The insider affirms no possession of undisclosed material information, and possible use of a 10b5-1 plan adds compliance strength. Still, two similar-sized disposals inside one quarter could be perceived negatively by some investors tracking executive confidence. Absent larger patterns or volume spikes, governance concerns remain low.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7930	510771.30	76528724	07/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/14/2025	Options Granted 04/12/2022	Issuer			7930	07/14/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Charles Prober 1900 South Norfolk Street Suite 310 San Mateo CA 94403	Common	06/13/2025	7942	489465.46

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Life360 (LIF) shares are being sold under this Form 144?

The insider plans to sell 7,930 common shares.

What is the estimated market value of the proposed Life360 share sale?

The aggregate market value is approximately $510,771.

When is the anticipated sale date for the Life360 insider transaction?

The filing lists an approximate sale date of 14 July 2025.

How many Life360 shares are outstanding according to the filing?

Life360 reports 76,528,724 shares outstanding.

Were there recent insider sales prior to this Form 144?

Yes. On 13 Jun 2025, the same insider sold 7,942 shares for $489,465.